Google: Analysts' New Targets, Estimates

Click here for Analysts' Upgrades, Downgrades.

Editor's Note: Green and red arrows refer to intraday stock price movement.

NEW YORK ( TheStreet) -- Alimera Sciences ( ALIM) price target cut at Citi to $12 from $15 after FDA did not approve lluvien NDA. Maintain Buy rating.

Google ( GOOG) target increased at Kaufman to $690. Company should benefit from strong domestic online holiday sales.

Rovi ( ROVI) estimates, target raised at Wedbush. Shares of ROVI now seen reaching $59, according to Wedbush Securities. Estimates also increased, to match the company's new guidance, following the SNIC acquisition.

Time Warner Cable ( TWC) target boosted at Argus to $75. Company is leveraged to benefit from a recovery in the economy. Buy rating.

This article was written by a staff member of TheStreet.

More from Stocks

China Makes Good on Car Tariff Pledge, Tesla Wins Big

China Makes Good on Car Tariff Pledge, Tesla Wins Big

Stocks Lower as Optimism Wanes Over China Trade Talks

Stocks Lower as Optimism Wanes Over China Trade Talks

Video: Jim Cramer Reacts to Tiffany's Better Than Expected Earnings

Video: Jim Cramer Reacts to Tiffany's Better Than Expected Earnings

Jim Cramer: Union Pacific Is Positive on NAFTA Talks

Jim Cramer: Union Pacific Is Positive on NAFTA Talks

Jim Cramer: I Remain Constructive on Micron Shares

Jim Cramer: I Remain Constructive on Micron Shares